Joinn Laboratories (China) Co.,Ltd. Share Price OTC Markets
Stocks
JNNL.Y
US47972L1089
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 31.6B 4.74B 4.25B 3.93B 3.56B 6.65B 451B 6.73B 47B 18.72B 236B 17.78B 17.41B 750B | P/E 2026 * |
39.4x | P/E 2027 * | 59.7x |
|---|---|---|---|---|---|
| Enterprise Value | 29.83B 4.47B 4.01B 3.71B 3.36B 6.28B 426B 6.35B 44.37B 17.67B 223B 16.79B 16.43B 708B | EV / Sales 2026 * |
16.1x | EV / Sales 2027 * | 13.5x |
| Free-Float |
63.27% | Yield 2026 * |
0.6% | Yield 2027 * | 0.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
Da Peng Gao
CEO | Chief Executive Officer | 44 | 27/01/2019 |
Ai Shui Yu
DFI | Director of Finance/CFO | 50 | 09/04/2020 |
Jing Liang Gu
PRN | Corporate Officer/Principal | 46 | 22/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Yu Xia Feng
CHM | Chairman | 62 | 10/08/1995 |
Da Peng Gao
BRD | Director/Board Member | 44 | 09/12/2012 |
Ye Li
CHM | Chairman | 44 | 09/12/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 4.74B | |
| +0.65% | -3.36% | +36.98% | +60.50% | 64.14B | |
| +1.76% | +1.27% | +11.82% | +81.21% | 55.53B | |
| -0.94% | +0.99% | +10.45% | +100.19% | 53.03B | |
| +2.76% | +0.87% | +27.92% | +55.07% | 45.99B | |
| +2.00% | -3.39% | +17.83% | +119.04% | 42.45B | |
| +1.34% | -2.86% | +224.43% | +914.08% | 40.45B | |
| +0.64% | -3.95% | +11.15% | +45.57% | 32.25B | |
| +29.06% | +47.63% | +107.12% | +92.73% | 34.47B | |
| -2.89% | -0.57% | +23.02% | -10.89% | 24.23B | |
| Average | +3.44% | +4.08% | +52.30% | +161.94% | 43.62B | |
| Weighted average by Cap. | +3.29% | +3.49% | +49.20% | +159.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.86B 279M 250M 231M 209M 391M 26.54B 396M 2.76B 1.1B 13.89B 1.05B 1.02B 44.1B | 2.19B 328M 294M 272M 246M 460M 31.23B 466M 3.25B 1.3B 16.34B 1.23B 1.2B 51.88B |
| Net income | 788M 118M 106M 98.03M 88.78M 166M 11.26B 168M 1.17B 467M 5.89B 443M 434M 18.7B | 374M 56.03M 50.27M 46.48M 42.09M 78.64M 5.34B 79.59M 556M 221M 2.79B 210M 206M 8.86B |
| Net Debt | -1.77B -265M -238M -220M -199M -373M -25.28B -377M -2.63B -1.05B -13.23B -996M -975M -41.99B | -2.03B -305M -274M -253M -229M -428M -29.06B -433M -3.03B -1.21B -15.21B -1.14B -1.12B -48.27B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
